⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

January 1, 1993Leukemia & lymphoma/Leukemia and lymphoma

Treatment of Myelodysplastic Syndromes with AML-Type Chemotherapy

Elihu H. Estey Sherry Pierce Hagop M. Kantarjian Susan O’Brien Miloslav Beran Michael Andreeff SM Escudier Charles Koller Steven M. Kornblau Lester E. Robertson Michael J. Keating

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Click to increase image sizeClick to decrease image sizeKey Words: Myelodysplastic syndromesAMLchemotherapypre-leukemiasmoldering leukemia

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Estey et al. (1993) studied this question.

synapsesocial.com/papers/6a154135cb801b7f954e465b https://doi.org/10.3109/10428199309064263

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Fludarabine and Arabinosylcytosine Therapy of Refractory and Relapsed Acute Myelogenous LeukemiaOriginal Research · 1993 · 158 citations
2Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy.In Vitro Study · 1993 · 330 citations
3Smoldering Acute LeukemiaOriginal Research · 1963 · 151 citations
4Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemiaPrognostic Study · 1980 · 285 citations
5The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromesOriginal Research · 1986 · 128 citations
6Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapyPrognostic Study · 2008 · 129 citations
7Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patientsOriginal Research · 1989 · 64 citations
8Projected population size by treatment line in diffuse large B-cell lymphoma in the United States, 2024–2028Leukemia & lymphoma/Leukemia and lymphoma · 2026
9Perniosis-like lesions as an extramedullary manifestation preceding a chronic myelomonocytic leukemia diagnosis: a clinicopathological and molecular descriptionLeukemia & lymphoma/Leukemia and lymphoma · 2026
10Patient empowerment in Hodgkin Lymphoma (HL) through continuously accessible information resourcesLeukemia & lymphoma/Leukemia and lymphoma · 2026

More from Leukemia & lymphoma/Leukemia and lymphoma

More from The University of Texas MD Anderson Cancer Center